Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1992 Apr;33(4):357-63.
doi: 10.1111/j.1365-2125.1992.tb04052.x.

The treatment of osteoarthritis

Affiliations
Review

The treatment of osteoarthritis

A C Jones et al. Br J Clin Pharmacol. 1992 Apr.

Abstract

1. The treatment of osteoarthritis is currently purely symptomatic. To enable rational therapy, careful clinical assessment is necessary to identify the origin of symptoms. Often, effective therapy can result from a biomechanical approach such as surgery, orthotics, physiotherapy and dieting. If drugs are required, there is little evidence that the current over-reliance on non-steroidal anti-inflammatory drugs (NSAIDs) is justified. Full dose regular paracetamol should be the first line of analgesic therapy. In the majority of patients, simple analgesics are probably as effective as NSAIDs. If NSAIDs are used it is necessary to review regularly their use and to be aware of potential toxicity. 2. Many alternative strategies of pain management such as topical preparations, intra-articular steroid injections, acupuncture, radiosynovectomy, transcutaneous nerve stimulation and anti-depressants, may be effective but their precise place in the armamentarium is not yet fully established. 3. The realisation that osteoarthritis is not a passive 'wear and tear' phenomenon but an active process that may be potentially modified, has led to interest in 'chondroprotective' agents, which may beneficially affect the osteoarthritic process. To date there are no convincing data available that such agents are, in fact, chondroprotective in humans.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Rheumatol. 1982 Sep-Oct;9(5):723-6 - PubMed
    1. Br Med J. 1980 Jan 12;280(6207):75-8 - PubMed
    1. J Rheumatol. 1980 Nov-Dec;7(6):850-6 - PubMed
    1. Ann Rheum Dis. 1981 Feb;40(1):75-8 - PubMed
    1. Aliment Pharmacol Ther. 1988;2 Suppl 1:131-8 - PubMed

Publication types

MeSH terms

Substances